Juvaris BioTherapeutics' Series A Round

Juvaris BioTherapeutics raised a round of funding on November 09, 2007. Investors include Kleiner Perkins Caufield & Byers.

Juvaris BioTherapeutics, Inc. is developing adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The Company's platform technology induces immunostimulation via cationic…

Articles about Juvaris BioTherapeutics' Series A Round: